Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立,并于2020年7月在德克萨斯州重新注册成立,总部位于德克萨斯州欧文。他们是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱。他们开发并商业化创新解决方案,通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健。他们的整个精准医疗解决方案组合旨在造福患者,最初的重点是肿瘤学,并服务于临床、学术和生物制药市场。
董事
名称
职位
Brian J. Brille
Executive Vice President and Vice Chairman
David D. Halbert
Chairman and Chief Executive Officer and Founder
George H. Poste
Vice Chairman
Jonathan Knowles
Vice Chairman
Danny Phillips
Director
David Fredrickson
Director
Jeffrey Vacirca
Director
Jon S. Halbert
Director
Joseph E. Gilliam
Director
Laura I. Johansen
Director
Lloyd B. Minor
Director
Peter M. Castleman
Director
股东
名称
职位
David D. Halbert
Chairman and Chief Executive Officer and Founder
J. Russel Denton
General Counsel and Secretary and Senior Vice President
Luke Power
Chief Accounting Officer and Chief Financial Officer and Senior Vice President